Aggravation apparente d’un psoriasis révélant un surdosage en méthotrexate

[1]  Jared M. Campbell,et al.  Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses , 2016, Cancer Chemotherapy and Pharmacology.

[2]  P. Wolkenstein,et al.  Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker. , 2015, Journal of the American Academy of Dermatology.

[3]  H. Mayan,et al.  Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients. , 2014, Autoimmunity reviews.

[4]  Kelly B. Conner,et al.  Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity. , 2014, Dermatology online journal.

[5]  S. Meehan,et al.  Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum. , 2014, Dermatology online journal.

[6]  V. Jain,et al.  Inflamed psoriatic plaques: Drug toxicity or disease exacerbation? , 2013, Indian journal of pharmacology.

[7]  J. Reichenberg,et al.  Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue. , 2011, Dermatology online journal.

[8]  R. Haber,et al.  Methotrexate-Induced Cutaneous Ulcers in a Nonpsoriatic Patient: Case Report and Review of the Literature , 2011, Journal of cutaneous medicine and surgery.

[9]  K. Schmiegelow.  Advances in individual prediction of methotrexate toxicity: a review , 2009, British journal of haematology.

[10]  B. Strober,et al.  Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. , 2009, Journal of the American Academy of Dermatology.

[11]  J. Breneman,et al.  Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides , 2008, Therapeutics and clinical risk management.

[12]  C. Bangert,et al.  Methotrexate in dermatology , 2007, Dermatologic therapy.

[13]  E. Bröcker,et al.  Methotrexate-induced toxic epidermal necrolysis-like skin toxicity. , 2007, European journal of dermatology : EJD.

[14]  J. Kremer,et al.  Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[15]  U. Haustein,et al.  Methotrexate in psoriasis: 26 years’ experience with low‐dose long‐term treatment , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[16]  Y. Assaraf,et al.  Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin , 1998, Archives of Dermatological Research.

[17]  B. Wilson,et al.  Erosion of psoriatic plaques: an early sign of methotrexate toxicity. , 1996, Journal of the American Academy of Dermatology.

[18]  B. Guillot,et al.  [Acute methotrexate poisoning: apropos of 16 cases reported to the Paris Poison Control Center and review of the literature]. , 1996, The´rapie (Paris).